Cargando…
Pricing the global health risks of the COVID-19 pandemic
Policies to address the coronavirus disease 2019 (COVID-19) require a balancing of the health risk reductions and the costs of economic dislocations. Application of the value of a statistical life (VSL) to monetize COVID-19 deaths produces a U.S. mortality cost estimate of $1.4 trillion for deaths i...
Autor principal: | Viscusi, W. Kip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604649/ https://www.ncbi.nlm.nih.gov/pubmed/33162671 http://dx.doi.org/10.1007/s11166-020-09337-2 |
Ejemplares similares
-
The global COVID-19 mortality cost report card: 2020, 2021, and 2022
por: Viscusi, W. Kip
Publicado: (2023) -
On the effects of Covid-19 pandemic on stock prices: an imminent global threat
por: Fasanya, Ismail, et al.
Publicado: (2022) -
The effect of global price movements on the energy sector commodity on bitcoin price movement during the COVID-19 pandemic
por: Meiryani, Meiryani, et al.
Publicado: (2022) -
Catastrophic Risk: Waking Up to the Reality of a Pandemic?
por: Pike, Jamison, et al.
Publicado: (2020) -
Pricing extreme mortality risk in the wake of the COVID-19 pandemic
por: Li, Han, et al.
Publicado: (2023)